{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T23:48:28Z","timestamp":1772063308582,"version":"3.50.1"},"publisher-location":"Berlin, Heidelberg","reference-count":91,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/82_2025_335","type":"book-chapter","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T08:51:02Z","timestamp":1764665462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["EBNA2 and EBNA-LP: The Earliest Viral Latency Proteins"],"prefix":"10.1007","author":[{"given":"Jana M.","family":"Cable","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna C.","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micah A.","family":"Luftig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"issue":"1","key":"335_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006769","volume":"14","author":"T Alandijany","year":"2018","unstructured":"Alandijany T, Roberts APE, Conn KL, Loney C, McFarlane S, Orr A, Boutell C (2018) Distinct temporal roles for the promyelocytic leukaemia (PML) protein in the sequential regulation of intracellular host immunity to HSV-1 infection. PLoS Pathog 14(1):e1006769. https:\/\/doi.org\/10.1371\/journal.ppat.1006769","journal-title":"PLoS Pathog"},{"issue":"22","key":"335_CR2","doi-asserted-by":"crossref","first-page":"10309","DOI":"10.1128\/JVI.01220-16","volume":"90","author":"ER Albright","year":"2016","unstructured":"Albright ER, Kalejta RF (2016) Canonical and variant forms of histone H3 are deposited onto the human cytomegalovirus genome during lytic and latent infections. J Virol 90(22):10309","journal-title":"J Virol"},{"issue":"11","key":"335_CR3","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.1128\/JVI.00469-14","volume":"88","author":"J Berscheminski","year":"2014","unstructured":"Berscheminski J, Wimmer P, Brun J, Ip WH, Groitl P, Horlacher T, Jaffray E, Hay RT, Dobner T, Schreiner S (2014) Sp100 isoform-specific regulation of human adenovirus 5 gene expression. J Virol 88(11):6076\u20136092. https:\/\/doi.org\/10.1128\/JVI.00469-14","journal-title":"J Virol"},{"issue":"25","key":"335_CR4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2022495118","volume":"118","author":"EN Bonglack","year":"2021","unstructured":"Bonglack EN, Messinger JE, Cable JM, Ch\u2019ng J, Parnell KM, Reinoso-Vizca\u00edno NM, Barry AP, Russell VS, Dave SS, Christofk HR, Luftig MA (2021) Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas. Proc Natl Acad Sci USA 118(25):e2022495118. https:\/\/doi.org\/10.1073\/pnas.2022495118","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"335_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011950","volume":"20","author":"JM Cable","year":"2024","unstructured":"Cable JM, Reinoso-Vizcaino NM, White RE, Luftig MA (2024) Epstein-Barr virus protein EBNA-LP engages YY1 through leucine-rich motifs to promote na\u00efve B cell transformation. PLoS Pathog 20(7):e1011950. https:\/\/doi.org\/10.1371\/journal.ppat.1011950","journal-title":"PLoS Pathog"},{"issue":"25","key":"335_CR6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2426339122","volume":"122","author":"JM Cable","year":"2025","unstructured":"Cable JM, Wongwiwat W, Grabowski JC, White RE, Luftig MA (2025) Sp140L functions as a herpesvirus restriction factor suppressing viral transcription and activating interferon-stimulated genes. Proc Natl Acad Sci 122(25):e2426339122. https:\/\/doi.org\/10.1073\/pnas.2426339122","journal-title":"Proc Natl Acad Sci"},{"key":"335_CR7","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.40228","volume":"7","author":"JM Cabral","year":"2018","unstructured":"Cabral JM, Oh HS, Knipe DM (2018) ATRX promotes maintenance of herpes simplex virus heterochromatin during chromatin stress. eLife 7:e40228. https:\/\/doi.org\/10.7554\/eLife.40228","journal-title":"eLife"},{"issue":"23","key":"335_CR8","doi-asserted-by":"publisher","first-page":"9558","DOI":"10.1073\/pnas.86.23.9558","volume":"86","author":"JI Cohen","year":"1989","unstructured":"Cohen JI, Wang F, Mannick J, Kieff E (1989) Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci 86(23):9558\u20139562. https:\/\/doi.org\/10.1073\/pnas.86.23.9558","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"335_CR9","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1128\/jvi.64.3.1002-1013.1990","volume":"64","author":"M Cordier","year":"1990","unstructured":"Cordier M, Calender A, Billaud M, Zimber U, Rousselet G, Pavlish O, Banchereau J, Tursz T, Bornkamm G, Lenoir GM (1990) Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. J Virol 64(3):1002\u20131013. https:\/\/doi.org\/10.1128\/jvi.64.3.1002-1013.1990","journal-title":"J Virol"},{"issue":"21","key":"335_CR10","doi-asserted-by":"publisher","first-page":"11890","DOI":"10.1093\/nar\/gkaa828","volume":"48","author":"A Corpet","year":"2020","unstructured":"Corpet A, Kleijwegt C, Roubille S, Juillard F, Jacquet K, Texier P, Lomonte P (2020) PML nuclear bodies and chromatin dynamics: catch me if you can! Nucleic Acids Res 48(21):11890\u201311912. https:\/\/doi.org\/10.1093\/nar\/gkaa828","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"335_CR11","doi-asserted-by":"crossref","first-page":"e0204422","DOI":"10.1128\/mbio.02044-22","volume":"13","author":"H Dong","year":"2022","unstructured":"Dong H, Wu W, Li J, Ma Y, Deng X, Guo D, Xu P (2022) PML body component Sp100A is a cytosolic responder to IFN and activator of antiviral ISGs. mBio 13(6):e0204422","journal-title":"mBio"},{"issue":"11","key":"335_CR12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1089\/jir.2008.0023","volume":"28","author":"CW Echendu","year":"2008","unstructured":"Echendu CW, Ling PD (2008) Regulation of Sp100A subnuclear localization and transcriptional function by EBNA-LP and interferon. J Interf Cytokine Res 28(11):667\u2013678. https:\/\/doi.org\/10.1089\/jir.2008.0023","journal-title":"J Interf Cytokine Res"},{"issue":"6","key":"335_CR13","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1128\/JVI.02308-07","volume":"82","author":"RD Everett","year":"2008","unstructured":"Everett RD, Parada C, Gripon P, Sirma H, Orr A (2008) Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100. J Virol 82(6):2661\u20132672. https:\/\/doi.org\/10.1128\/JVI.02308-07","journal-title":"J Virol"},{"issue":"5","key":"335_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004910","volume":"11","author":"A Friberg","year":"2015","unstructured":"Friberg A, Thumann S, Hennig J, Zou P, N\u00f6ssner E, Ling PD, Sattler M, Kempkes B (2015) The EBNA-2 N-terminal transactivation domain folds into a dimeric structure required for target gene activation. PLoS Pathog 11(5):e1004910. https:\/\/doi.org\/10.1371\/journal.ppat.1004910","journal-title":"PLoS Pathog"},{"issue":"10","key":"335_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006664","volume":"13","author":"LV Glaser","year":"2017","unstructured":"Glaser LV, Rieger S, Thumann S, Beer S, Kuklik-Roos C, Martin DE, Maier KC, Harth-Hertle ML, Gr\u00fcning B, Backofen R, Krebs S, Blum H, Zimmer R, Erhard F, Kempkes B (2017) EBF1 binds to EBNA2 and promotes the assembly of EBNA2 chromatin complexes in B cells. PLoS Pathog 13(10):e1006664. https:\/\/doi.org\/10.1371\/journal.ppat.1006664","journal-title":"PLoS Pathog"},{"issue":"7","key":"335_CR16","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1128\/jvi.65.7.3779-3788.1991","volume":"65","author":"FA Gr\u00e4sser","year":"1991","unstructured":"Gr\u00e4sser FA, Haiss P, G\u00f6ttel S, Mueller-Lantzsch N (1991) Biochemical characterization of Epstein-Barr virus nuclear antigen 2A. J Virol 65(7):3779\u20133788. https:\/\/doi.org\/10.1128\/jvi.65.7.3779-3788.1991","journal-title":"J Virol"},{"issue":"3","key":"335_CR17","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/S0006-291X(05)81604-3","volume":"186","author":"FA Gr\u00e4sser","year":"1992","unstructured":"Gr\u00e4sser FA, G\u00f6ttel S, Haiss P, Boldyreff B, Issinger OG, Mueller-Lantzsch N (1992) Phosphorylation of the epstein-barr virus nuclear antigen 2. Biochem Biophys Res Commun 186(3):1694\u20131701. https:\/\/doi.org\/10.1016\/S0006-291X(05)81604-3","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"335_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.virol.2009.11.023","volume":"397","author":"H Gross","year":"2010","unstructured":"Gross H, Barth S, Palermo RD, Mamiani A, Hennard C, Zimber-Strobl U, West MJ, Kremmer E, Gr\u00e4sser FA (2010) Asymmetric Arginine dimethylation of Epstein\u2013Barr virus nuclear antigen 2 promotes DNA targeting. Virology 397(2):299\u2013310. https:\/\/doi.org\/10.1016\/j.virol.2009.11.023","journal-title":"Virology"},{"issue":"16","key":"335_CR19","doi-asserted-by":"publisher","first-page":"7568","DOI":"10.1073\/pnas.91.16.7568","volume":"91","author":"SR Grossman","year":"1994","unstructured":"Grossman SR, Johannsen E, Tong X, Yalamanchili R, Kieff E (1994) The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proc Natl Acad Sci 91(16):7568\u20137572. https:\/\/doi.org\/10.1073\/pnas.91.16.7568","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"335_CR20","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1128\/JVI.02137-15","volume":"90","author":"C Habiger","year":"2016","unstructured":"Habiger C, J\u00e4ger G, Walter M, Iftner T, Stubenrauch F (2016) Interferon kappa inhibits human papillomavirus 31 transcription by inducing Sp100 proteins. J Virol 90(2):694\u2013704. https:\/\/doi.org\/10.1128\/JVI.02137-15","journal-title":"J Virol"},{"issue":"6232","key":"335_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/340393a0","volume":"340","author":"W Hammerschmidt","year":"1989","unstructured":"Hammerschmidt W, Sugden B (1989) Genetic analysis of immortalizing functions of Epstein\u2013Barr virus in human B lymphocytes. Nature 340(6232):393\u2013397. https:\/\/doi.org\/10.1038\/340393a0","journal-title":"Nature"},{"issue":"5","key":"335_CR22","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1128\/JVI.75.5.2475-2481.2001","volume":"75","author":"I Han","year":"2001","unstructured":"Han I, Harada S, Weaver D, Xue Y, Lane W, Orstavik S, Skalhegg B, Kieff E (2001) EBNA-LP associates with cellular proteins including DNA-PK and HA95. J Virol 75(5):2475\u20132481. https:\/\/doi.org\/10.1128\/JVI.75.5.2475-2481.2001","journal-title":"J Virol"},{"issue":"9","key":"335_CR23","doi-asserted-by":"publisher","first-page":"6611","DOI":"10.1128\/jvi.71.9.6611-6618.1997","volume":"71","author":"S Harada","year":"1997","unstructured":"Harada S, Kieff E (1997) Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation. J Virol 71(9):6611\u20136618. https:\/\/doi.org\/10.1128\/jvi.71.9.6611-6618.1997","journal-title":"J Virol"},{"issue":"5","key":"335_CR24","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41588-018-0102-3","volume":"50","author":"JB Harley","year":"2018","unstructured":"Harley JB, Chen X, Pujato M, Miller D, Maddox A, Forney C, Magnusen AF, Lynch A, Chetal K, Yukawa M, Barski A, Salomonis N, Kaufman KM, Kottyan LC, Weirauch MT (2018) Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat Genet 50(5):699\u2013707. https:\/\/doi.org\/10.1038\/s41588-018-0102-3","journal-title":"Nat Genet"},{"issue":"5168","key":"335_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1126\/science.8016657","volume":"265","author":"T Henkel","year":"1994","unstructured":"Henkel T, Ling PD, Hayward SD, Peterson MG (1994) Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J\u03ba. Science 265(5168):92\u201395. https:\/\/doi.org\/10.1126\/science.8016657","journal-title":"Science"},{"issue":"3","key":"335_CR26","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1128\/MCB.16.3.952","volume":"16","author":"JJ-D Hsieh","year":"1996","unstructured":"Hsieh JJ-D, Henkel T, Salmon P, Robey E, Peterson MG, Hayward SD (1996) Truncated mammalian Notch1 activates CBF1\/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol Cell Biol 16(3):952\u2013959. https:\/\/doi.org\/10.1128\/MCB.16.3.952","journal-title":"Mol Cell Biol"},{"issue":"4","key":"335_CR27","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.chom.2017.09.001","volume":"22","author":"S Jiang","year":"2017","unstructured":"Jiang S, Zhou H, Liang J, Gerdt C, Wang C, Ke L, Schmidt SCS, Narita Y, Ma Y, Wang S, Colson T, Gewurz B, Li G, Kieff E, Zhao B (2017) The Epstein-Barr virus Regulome in Lymphoblastoid cells. Cell Host Microbe 22(4):561\u2013573.e4. https:\/\/doi.org\/10.1016\/j.chom.2017.09.001","journal-title":"Cell Host Microbe"},{"issue":"5","key":"335_CR28","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.1128\/JVI.73.5.4481-4484.1999","volume":"73","author":"C Kaiser","year":"1999","unstructured":"Kaiser C, Laux G, Eick D, Jochner N, Bornkamm GW, Kempkes B (1999) The proto-oncogene c- myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. J Virol 73(5):4481\u20134484. https:\/\/doi.org\/10.1128\/JVI.73.5.4481-4484.1999","journal-title":"J Virol"},{"issue":"5","key":"335_CR29","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/ijc.11124","volume":"105","author":"E Kashuba","year":"2003","unstructured":"Kashuba E, Mattsson K, Pokrovskaja K, Kiss C, Protopopova M, Ehlin-Henriksson B, Klein G, Szekely L (2003) EBV-encoded EBNA-5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF-expressing cells. Int J Cancer 105(5):644\u2013653. https:\/\/doi.org\/10.1002\/ijc.11124","journal-title":"Int J Cancer"},{"issue":"12","key":"335_CR30","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1099\/vir.0.19454-0","volume":"84","author":"K Kato","year":"2003","unstructured":"Kato K, Yokoyama A, Tohya Y, Akashi H, Nishiyama Y, Kawaguchi Y (2003) Identification of protein kinases responsible for phosphorylation of Epstein\u2013Barr virus nuclear antigen leader protein at serine-35, which regulates its coactivator function. J Gen Virol 84(12):3381\u20133392. https:\/\/doi.org\/10.1099\/vir.0.19454-0","journal-title":"J Gen Virol"},{"issue":"3","key":"335_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000341","volume":"5","author":"GL Kelly","year":"2009","unstructured":"Kelly GL, Long HM, Stylianou J, Thomas WA, Leese A, Bell AI, Bornkamm GW, Mautner J, Rickinson AB, Rowe M (2009) An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in Burkitt lymphomagenesis: The Wp\/BHRF1 link. PLoS Pathog 5(3):e1000341. https:\/\/doi.org\/10.1371\/journal.ppat.1000341","journal-title":"PLoS Pathog"},{"issue":"1","key":"335_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/j.1460-2075.1995.tb06978.x","volume":"14","author":"B Kempkes","year":"1995","unstructured":"Kempkes B, Spitkovsky D, Jansen-D\u00fcrr P, Ellwart JW, Kremmer E, Delecluse HJ, Rottenberger C, Bornkamm GW, Hammerschmidt W (1995) B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO J 14(1):88\u201396. https:\/\/doi.org\/10.1002\/j.1460-2075.1995.tb06978.x","journal-title":"EMBO J"},{"issue":"3","key":"335_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004785","volume":"11","author":"Y-E Kim","year":"2015","unstructured":"Kim Y-E, Ahn J-H (2015) Positive role of Promyelocytic leukemia protein in type I interferon response and its regulation by human cytomegalovirus. PLoS Pathog 11(3):e1004785. https:\/\/doi.org\/10.1371\/journal.ppat.1004785","journal-title":"PLoS Pathog"},{"issue":"22","key":"335_CR34","doi-asserted-by":"publisher","first-page":"11928","DOI":"10.1128\/jvi.00758-11","volume":"85","author":"Y-E Kim","year":"2011","unstructured":"Kim Y-E, Lee J-H, Kim ET, Shin HJ, Gu SY, Seol HS, Ling PD, Lee CH, Ahn J-H (2011) Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression. J Virol 85(22):11928\u201311937. https:\/\/doi.org\/10.1128\/jvi.00758-11","journal-title":"J Virol"},{"issue":"11","key":"335_CR35","doi-asserted-by":"publisher","first-page":"7885","DOI":"10.1128\/jvi.70.11.7885-7893.1996","volume":"70","author":"MK Kitay","year":"1996","unstructured":"Kitay MK, Rowe DT (1996) Cell cycle stage-specific phosphorylation of the Epstein-Barr virus immortalization protein EBNA-LP. J Virol 70(11):7885\u20137893. https:\/\/doi.org\/10.1128\/jvi.70.11.7885-7893.1996","journal-title":"J Virol"},{"key":"335_CR36","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.80156","volume":"12","author":"C Kleijwegt","year":"2023","unstructured":"Kleijwegt C, Bressac F, Seurre C, Bouchereau W, Cohen C, Texier P, Simonet T, Schaeffer L, Lomonte P, Corpet A (2023) Interplay between PML NBs and HIRA for H3.3 dynamics following type I interferon stimulus. eLife 12:e80156. https:\/\/doi.org\/10.7554\/eLife.80156","journal-title":"eLife"},{"issue":"20","key":"335_CR37","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1038\/sj.emboj.7600820","volume":"24","author":"PD Ling","year":"2005","unstructured":"Ling PD, Peng RS, Nakajima A, Yu JH, Tan J, Moses SM, Yang W-H, Zhao B, Kieff E, Bloch KD, Bloch DB (2005) Mediation of Epstein\u2013Barr virus EBNA-LP transcriptional coactivation by Sp100. EMBO J 24(20):3565\u20133575. https:\/\/doi.org\/10.1038\/sj.emboj.7600820","journal-title":"EMBO J"},{"issue":"14","key":"335_CR38","doi-asserted-by":"publisher","first-page":"7109","DOI":"10.1128\/jvi.00654-09","volume":"83","author":"PD Ling","year":"2009","unstructured":"Ling PD, Tan J, Peng R (2009) Nuclear-cytoplasmic shuttling is not required for the Epstein-Barr virus EBNA-LP transcriptional Coactivation function. J Virol 83(14):7109\u20137116. https:\/\/doi.org\/10.1128\/jvi.00654-09","journal-title":"J Virol"},{"key":"335_CR39","doi-asserted-by":"publisher","unstructured":"Liu, C.-D., Cheng, C.-P., Fang, J.-S., Chen, L.-C., Zhao, B., Kieff, E., & Peng, C.-W. (2013). Modulation of Epstein\u2013Barr virus nuclear antigen 2-dependent transcription by protein arginine methyltransferase 5. Biochem Biophys Res Commun, 430(3), 1097\u20131102. https:\/\/doi.org\/10.1016\/j.bbrc.2012.12.032","DOI":"10.1016\/j.bbrc.2012.12.032"},{"issue":"1","key":"335_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005339","volume":"12","author":"F Lu","year":"2016","unstructured":"Lu F, Chen H-S, Kossenkov AV, DeWispeleare K, Won K-J, Lieberman PM (2016a) EBNA2 drives formation of new chromosome binding sites and target genes for B-cell master regulatory transcription factors RBP-j\u03ba and EBF1. PLoS Pathog 12(1):e1005339. https:\/\/doi.org\/10.1371\/journal.ppat.1005339","journal-title":"PLoS Pathog"},{"issue":"21","key":"335_CR41","doi-asserted-by":"publisher","first-page":"9664","DOI":"10.1128\/JVI.01224-16","volume":"90","author":"Y Lu","year":"2016","unstructured":"Lu Y, Orr A, Everett RD (2016b) Stimulation of the replication of ICP0-null mutant herpes simplex virus 1 and pp71-deficient human cytomegalovirus by Epstein-Barr virus tegument protein BNRF1. J Virol 90(21):9664\u20139673. https:\/\/doi.org\/10.1128\/JVI.01224-16","journal-title":"J Virol"},{"issue":"6","key":"335_CR42","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.cels.2023.05.008","volume":"14","author":"CH Ludwig","year":"2023","unstructured":"Ludwig CH, Thurm AR, Morgens DW, Yang KJ, Tycko J, Bassik MC, Glaunsinger BA, Bintu L (2023) High-throughput discovery and characterization of viral transcriptional effectors in human cells. Cell Syst 14(6):482\u2013500.e8. https:\/\/doi.org\/10.1016\/j.cels.2023.05.008","journal-title":"Cell Syst"},{"issue":"12","key":"335_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaf629","volume":"53","author":"D Maestri","year":"2025","unstructured":"Maestri D, Caruso LB, Cable JM, Sklutuis R, Preston-Alp S, White RE, Luftig MA, Tempera I (2025) EBNA leader protein orchestrates chromatin architecture remodeling during Epstein-Barr virus-induced B cell transformation. Nucleic Acids Res 53(12):gkaf629. https:\/\/doi.org\/10.1093\/nar\/gkaf629","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"335_CR44","doi-asserted-by":"publisher","first-page":"10657","DOI":"10.1093\/nar\/gkab787","volume":"49","author":"E Manet","year":"2021","unstructured":"Manet E, Polv\u00e8che H, Mure F, Mrozek-Gorska P, Roisn\u00e9-Hamelin F, Hammerschmidt W, Auboeuf D, Gruffat H (2021) Modulation of alternative splicing during early infection of human primary B lymphocytes with Epstein-Barr virus (EBV): A novel function for the viral EBNA-LP protein. Nucleic Acids Res 49(18):10657\u201310676. https:\/\/doi.org\/10.1093\/nar\/gkab787","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"335_CR45","doi-asserted-by":"publisher","first-page":"6826","DOI":"10.1128\/jvi.65.12.6826-6837.1991","volume":"65","author":"JB Mannick","year":"1991","unstructured":"Mannick JB, Cohen JI, Birkenbach M, Marchini A, Kieff E (1991) The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J Virol 65(12):6826\u20136837. https:\/\/doi.org\/10.1128\/jvi.65.12.6826-6837.1991","journal-title":"J Virol"},{"issue":"12","key":"335_CR46","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1099\/0022-1317-82-12-3067","volume":"82","author":"EM McCann","year":"2001","unstructured":"McCann EM, Kelly GL, Rickinson AB, Bell AI (2001) Genetic analysis of the Epstein\u2013Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 function. J Gen Virol 82(12):3067\u20133079. https:\/\/doi.org\/10.1099\/0022-1317-82-12-3067","journal-title":"J Gen Virol"},{"issue":"9","key":"335_CR47","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1128\/JVI.07161-11","volume":"86","author":"MJ McClellan","year":"2012","unstructured":"McClellan MJ, Khasnis S, Wood CD, Palermo RD, Schlick SN, Kanhere AS, Jenner RG, West MJ (2012) Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elements. J Virol 86(9):5165\u20135178. https:\/\/doi.org\/10.1128\/JVI.07161-11","journal-title":"J Virol"},{"key":"335_CR48","doi-asserted-by":"publisher","unstructured":"McFadden K, Hafez AY, Kishton R, Messinger JE, Nikitin PA, Rathmell JC, Luftig MA (2016) Metabolic stress is a barrier to Epstein\u2013Barr virus-mediated B-cell immortalization. Proc Natl Acad Sci U S A 113(6). https:\/\/doi.org\/10.1073\/pnas.1517141113","DOI":"10.1073\/pnas.1517141113"},{"issue":"3","key":"335_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007667","volume":"15","author":"S McFarlane","year":"2019","unstructured":"McFarlane S, Orr A, Roberts APE, Conn KL, Iliev V, Loney C, Da Silva Filipe A, Smollett K, Gu Q, Robertson N, Adams PD, Rai TS, Boutell C (2019) The histone chaperone HIRA promotes the induction of host innate immune defences in response to HSV-1 infection. PLoS Pathog 15(3):e1007667. https:\/\/doi.org\/10.1371\/journal.ppat.1007667","journal-title":"PLoS Pathog"},{"issue":"14","key":"335_CR50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2418783122","volume":"122","author":"R Mechelli","year":"2025","unstructured":"Mechelli R, Umeton R, Bellucci G, Bigi R, Rinaldi V, Angelini DF, Guerrera G, Pignalosa FC, Ilari S, Patrone M, Srinivasan S, Cerono G, Romano S, Buscarinu MC, Martire S, Malucchi S, Landi D, Lorefice L, Pizzolato Umeton R et al (2025) A disease-specific convergence of host and Epstein\u2013Barr virus genetics in multiple sclerosis. Proc Natl Acad Sci 122(14):e2418783122. https:\/\/doi.org\/10.1073\/pnas.2418783122","journal-title":"Proc Natl Acad Sci"},{"issue":"6704","key":"335_CR51","doi-asserted-by":"publisher","first-page":"eadk4898","DOI":"10.1126\/science.adk4898","volume":"385","author":"B M\u00fcller-Durovic","year":"2024","unstructured":"M\u00fcller-Durovic B, J\u00e4ger J, Engelmann C, Schuhmachers P, Altermatt S, Schlup Y, Duthaler U, Makowiec C, Unterstab G, Roffeis S, Xhafa E, Assmann N, Trulsson F, Steiner R, Edwards-Hicks J, West J, Turner L, Develioglu L, Ivanek R et al (2024) A metabolic dependency of EBV can be targeted to hinder B cell transformation. Science 385(6704):eadk4898. https:\/\/doi.org\/10.1126\/science.adk4898","journal-title":"Science"},{"issue":"16","key":"335_CR52","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.1128\/JVI.02164-05","volume":"80","author":"DG Negorev","year":"2006","unstructured":"Negorev DG, Vladimirova OV, Ivanov A, Rauscher F, Maul GG (2006) Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression. J Virol 80(16):8019\u20138029. https:\/\/doi.org\/10.1128\/JVI.02164-05","journal-title":"J Virol"},{"issue":"9","key":"335_CR53","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1091\/mbc.e12-09-0669","volume":"24","author":"A Newhart","year":"2013","unstructured":"Newhart A, Negorev DG, Rafalska-Metcalf IU, Yang T, Maul GG, Janicki SM (2013) Sp100A promotes chromatin decondensation at a cytomegalovirus-promoter\u2013regulated transcription site. Mol Biol Cell 24(9):1454\u20131468. https:\/\/doi.org\/10.1091\/mbc.e12-09-0669","journal-title":"Mol Biol Cell"},{"issue":"9","key":"335_CR54","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1128\/jvi.71.9.6619-6628.1997","volume":"71","author":"F Nitsche","year":"1997","unstructured":"Nitsche F, Bell A, Rickinson A (1997) Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain. J Virol 71(9):6619\u20136628. https:\/\/doi.org\/10.1128\/jvi.71.9.6619-6628.1997","journal-title":"J Virol"},{"issue":"1","key":"335_CR55","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1128\/JVI.74.1.379-389.2000","volume":"74","author":"R Peng","year":"2000","unstructured":"Peng R, Gordadze AV, Fuentes Panan\u00e1 EM, Wang F, Zong J, Hayward GS, Tan J, Ling PD (2000a) Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate Lymphocryptoviruses. J Virol 74(1):379\u2013389. https:\/\/doi.org\/10.1128\/JVI.74.1.379-389.2000","journal-title":"J Virol"},{"issue":"21","key":"335_CR56","doi-asserted-by":"publisher","first-page":"9953","DOI":"10.1128\/JVI.74.21.9953-9963.2000","volume":"74","author":"R Peng","year":"2000","unstructured":"Peng R, Tan J, Ling PD (2000b) Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2. J Virol 74(21):9953\u20139963. https:\/\/doi.org\/10.1128\/JVI.74.21.9953-9963.2000","journal-title":"J Virol"},{"key":"335_CR57","doi-asserted-by":"publisher","unstructured":"Peng C-W, Xue Y, Zhao B, Johannsen E, Kieff E, Harada S (2004a) Direct interactions between Epstein\u2013Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation. Proc Natl Acad Sci U S A 101(4):1033\u20131038. https:\/\/doi.org\/10.1073\/pnas.0307808100","DOI":"10.1073\/pnas.0307808100"},{"issue":"20","key":"335_CR58","doi-asserted-by":"publisher","first-page":"11439","DOI":"10.1128\/JVI.78.20.11439-11442.2004","volume":"78","author":"C-W Peng","year":"2004","unstructured":"Peng C-W, Zhao B, Kieff E (2004b) Four EBNA2 domains are important for EBNALP Coactivation. J Virol 78(20):11439\u201311442. https:\/\/doi.org\/10.1128\/JVI.78.20.11439-11442.2004","journal-title":"J Virol"},{"issue":"7","key":"335_CR59","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1128\/JVI.79.7.4492-4505.2005","volume":"79","author":"R Peng","year":"2005","unstructured":"Peng R, Moses SC, Tan J, Kremmer E, Ling PD (2005) The Epstein-Barr virus EBNA-LP protein preferentially Coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter. J Virol 79(7):4492\u20134505. https:\/\/doi.org\/10.1128\/JVI.79.7.4492-4505.2005","journal-title":"J Virol"},{"issue":"12","key":"335_CR60","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.1182\/blood-2006-08-040634","volume":"109","author":"C-W Peng","year":"2007","unstructured":"Peng C-W, Zhao B, Chen H-C, Chou M-L, Lai C-Y, Lin S-Z, Hsu H-Y, Kieff E (2007) Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2. Blood 109(12):5447\u20135454. https:\/\/doi.org\/10.1182\/blood-2006-08-040634","journal-title":"Blood"},{"issue":"7","key":"335_CR61","doi-asserted-by":"publisher","first-page":"e01771","DOI":"10.1128\/JVI.01771-19","volume":"94","author":"Q Peng","year":"2020","unstructured":"Peng Q, Wang L, Qin Z, Wang J, Zheng X, Wei L, Zhang X, Zhang X, Liu C, Li Z, Wu Y, Li G, Yan Q, Ma J (2020) Phase separation of Epstein-Barr virus EBNA2 and its coactivator EBNALP controls gene expression. J Virol 94(7):e01771\u2013e01719. https:\/\/doi.org\/10.1128\/JVI.01771-19","journal-title":"J Virol"},{"issue":"2","key":"335_CR62","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.tibs.2004.12.001","volume":"30","author":"MJ Plevin","year":"2005","unstructured":"Plevin MJ, Mills MM, Ikura M (2005) The LxxLL motif: A multifunctional binding sequence in transcriptional regulation. Trends Biochem Sci 30(2):66\u201369. https:\/\/doi.org\/10.1016\/j.tibs.2004.12.001","journal-title":"Trends Biochem Sci"},{"key":"335_CR63","doi-asserted-by":"publisher","unstructured":"Portal D, Rosendorff A, Kieff E (2006) Epstein\u2013Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4. Proc Natl Acad Sci U S A 103(51):19278\u201319283. https:\/\/doi.org\/10.1073\/pnas.0609320103","DOI":"10.1073\/pnas.0609320103"},{"issue":"19","key":"335_CR64","doi-asserted-by":"publisher","first-page":"7808","DOI":"10.1073\/pnas.1104991108","volume":"108","author":"D Portal","year":"2011","unstructured":"Portal D, Zhao B, Calderwood MA, Sommermann T, Johannsen E, Kieff E (2011) EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding. Proc Natl Acad Sci 108(19):7808\u20137813. https:\/\/doi.org\/10.1073\/pnas.1104991108","journal-title":"Proc Natl Acad Sci"},{"key":"335_CR65","doi-asserted-by":"publisher","unstructured":"Portal D, Zhou H, Zhao B, Kharchenko PV, Lowry E, Wong L, Quackenbush J, Holloway D, Jiang S, Lu Y, Kieff E (2013) Epstein\u2013Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2. Proc Natl Acad Sci U S A 110(46):18537\u201318542. https:\/\/doi.org\/10.1073\/pnas.1317608110","DOI":"10.1073\/pnas.1317608110"},{"issue":"3","key":"335_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004656","volume":"11","author":"AM Price","year":"2015","unstructured":"Price AM, Luftig MA (2015) To be or not IIb: A multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis. PLoS Pathog 11(3):e1004656. https:\/\/doi.org\/10.1371\/journal.ppat.1004656","journal-title":"PLoS Pathog"},{"issue":"20","key":"335_CR67","doi-asserted-by":"publisher","first-page":"11096","DOI":"10.1128\/JVI.01069-12","volume":"86","author":"AM Price","year":"2012","unstructured":"Price AM, Tourigny JP, Forte E, Salinas RE, Dave SS, Luftig MA (2012) Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-\u03baB activation. J Virol 86(20):11096\u201311106. https:\/\/doi.org\/10.1128\/JVI.01069-12","journal-title":"J Virol"},{"issue":"20","key":"335_CR68","doi-asserted-by":"publisher","first-page":"11673","DOI":"10.1093\/nar\/gkx771","volume":"45","author":"TS Rai","year":"2017","unstructured":"Rai TS, Glass M, Cole JJ, Rather MI, Marsden M, Neilson M, Brock C, Humphreys IR, Everett RD, Adams PD (2017) Histone chaperone HIRA deposits histone H3.3 onto foreign viral DNA and contributes to anti-viral intrinsic immunity. Nucleic Acids Res 45(20):11673\u201311683. https:\/\/doi.org\/10.1093\/nar\/gkx771","journal-title":"Nucleic Acids Res"},{"key":"335_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.198015","volume":"285","author":"MC Rodr\u00edguez","year":"2020","unstructured":"Rodr\u00edguez MC, Dybas JM, Hughes J, Weitzman MD, Boutell C (2020) The HSV-1 ubiquitin ligase ICP0: modifying the cellular proteome to promote infection. Virus Res 285:198015. https:\/\/doi.org\/10.1016\/j.virusres.2020.198015","journal-title":"Virus Res"},{"issue":"2","key":"335_CR70","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/v16020183","volume":"16","author":"A Roy","year":"2024","unstructured":"Roy A, Ghosh A (2024) Epigenetic restriction factors (eRFs) in virus infection. Viruses 16(2):183. https:\/\/doi.org\/10.3390\/v16020183","journal-title":"Viruses"},{"issue":"6","key":"335_CR71","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1093\/nar\/gkt064","volume":"41","author":"S Schreiner","year":"2013","unstructured":"Schreiner S, B\u00fcrck C, Glass M, Groitl P, Wimmer P, Kinkley S, Mund A, Everett RD, Dobner T (2013) Control of human adenovirus type 5 gene expression by cellular Daxx\/ATRX chromatin-associated complexes. Nucleic Acids Res 41(6):3532\u20133550. https:\/\/doi.org\/10.1093\/nar\/gkt064","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"335_CR72","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1002\/j.1460-2075.1994.tb06634.x","volume":"13","author":"AJ Sinclair","year":"1994","unstructured":"Sinclair AJ, Palmero I, Peters G, Farrell PJ (1994) EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J 13(14):3321\u20133328. https:\/\/doi.org\/10.1002\/j.1460-2075.1994.tb06634.x","journal-title":"EMBO J"},{"issue":"8","key":"335_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010748","volume":"18","author":"A-C Stilp","year":"2022","unstructured":"Stilp A-C, Scherer M, K\u00f6nig P, F\u00fcrstberger A, Kestler HA, Stamminger T (2022) The chromatin remodeling protein ATRX positively regulates IRF3-dependent type I interferon production and interferon-induced gene expression. PLoS Pathog 18(8):e1010748. https:\/\/doi.org\/10.1371\/journal.ppat.1010748","journal-title":"PLoS Pathog"},{"issue":"4","key":"335_CR74","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1128\/jvi.70.4.2562-2568.1996","volume":"70","author":"L Szekely","year":"1996","unstructured":"Szekely L, Pokrovskaja K, Jiang WQ, De The H, Ringertz N, Klein G (1996) The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies. J Virol 70(4):2562\u20132568. https:\/\/doi.org\/10.1128\/jvi.70.4.2562-2568.1996","journal-title":"J Virol"},{"issue":"2","key":"335_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006890","volume":"14","author":"A Szymula","year":"2018","unstructured":"Szymula A, Palermo RD, Bayoumy A, Groves IJ, Ba Abdullah M, Holder B, White RE (2018) Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming na\u00efve B cells, and facilitates recruitment of transcription factors to the viral genome. PLoS Pathog 14(2):e1006890. https:\/\/doi.org\/10.1371\/journal.ppat.1006890","journal-title":"PLoS Pathog"},{"issue":"10","key":"335_CR76","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.1128\/jvi.68.10.6188-6197.1994","volume":"68","author":"X Tong","year":"1994","unstructured":"Tong X, Yalamanchili R, Harada S, Kieff E (1994) The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains. J Virol 68(10):6188\u20136197. https:\/\/doi.org\/10.1128\/jvi.68.10.6188-6197.1994","journal-title":"J Virol"},{"issue":"11","key":"335_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002376","volume":"7","author":"K Tsai","year":"2011","unstructured":"Tsai K, Thikmyanova N, Wojcechowskyj JA, Delecluse H-J, Lieberman PM (2011) EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcription. PLoS Pathog 7(11):e1002376. https:\/\/doi.org\/10.1371\/journal.ppat.1002376","journal-title":"PLoS Pathog"},{"issue":"24","key":"335_CR78","doi-asserted-by":"publisher","first-page":"14350","DOI":"10.1128\/JVI.01895-14","volume":"88","author":"K Tsai","year":"2014","unstructured":"Tsai K, Chan L, Gibeault R, Conn K, Dheekollu J, Domsic J, Marmorstein R, Schang LM, Lieberman PM (2014) Viral reprogramming of the Daxx histone H3.3 chaperone during early Epstein-Barr virus infection. J Virol 88(24):14350\u201314363. https:\/\/doi.org\/10.1128\/JVI.01895-14","journal-title":"J Virol"},{"issue":"10","key":"335_CR79","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1073\/pnas.84.10.3452","volume":"84","author":"F Wang","year":"1987","unstructured":"Wang F, Gregory CD, Rowe M, Rickinson AB, Wang D, Birkenbach M, Kikutani H, Kishimoto T, Kieff E (1987) Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc Natl Acad Sci 84(10):3452\u20133456. https:\/\/doi.org\/10.1073\/pnas.84.10.3452","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"335_CR80","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1073\/pnas.97.1.430","volume":"97","author":"L Wang","year":"2000","unstructured":"Wang L, Grossman SR, Kieff E (2000) Epstein\u2013Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. Proc Natl Acad Sci 97(1):430\u2013435. https:\/\/doi.org\/10.1073\/pnas.97.1.430","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"335_CR81","doi-asserted-by":"publisher","first-page":"e02155","DOI":"10.1128\/JVI.02155-17","volume":"92","author":"C Wang","year":"2018","unstructured":"Wang C, Zhou H, Xue Y, Liang J, Narita Y, Gerdt C, Zheng AY, Jiang R, Trudeau S, Peng C-W, Gewurz BE, Zhao B (2018) Epstein-Barr virus nuclear antigen leader protein coactivates EP300. J Virol 92(9):e02155\u2013e02117. https:\/\/doi.org\/10.1128\/JVI.02155-17","journal-title":"J Virol"},{"issue":"3","key":"335_CR82","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.cmet.2019.06.003","volume":"30","author":"LW Wang","year":"2019","unstructured":"Wang LW, Shen H, Nobre L, Ersing I, Paulo JA, Trudeau S, Wang Z, Smith NA, Ma Y, Reinstadler B, Nomburg J, Sommermann T, Cahir-McFarland E, Gygi SP, Mootha VK, Weekes MP, Gewurz BE (2019) Epstein-Barr-virus-induced one-carbon metabolism drives B cell transformation. Cell Metab 30(3):539\u2013555.e11. https:\/\/doi.org\/10.1016\/j.cmet.2019.06.003","journal-title":"Cell Metab"},{"issue":"1","key":"335_CR83","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/s41467-023-37347-6","volume":"14","author":"C Wang","year":"2023","unstructured":"Wang C, Liu X, Liang J, Narita Y, Ding W, Li D, Zhang L, Wang H, Leong MML, Hou I, Gerdt C, Jiang C, Zhong Q, Tang Z, Forney C, Kottyan L, Weirauch MT, Gewurz BE, Zeng M et al (2023) A DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth. Nat Commun 14(1):1598. https:\/\/doi.org\/10.1038\/s41467-023-37347-6","journal-title":"Nat Commun"},{"issue":"3","key":"335_CR84","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s44319-024-00357-6","volume":"26","author":"C Wang","year":"2025","unstructured":"Wang C, Leong MM, Ding W, Narita Y, Liu X, Wang H, Yiu SPT, Lee J, Zhao KRS, Cui A, Gewurz B, Hammerschmidt W, Teng M, Zhao B (2025) Viral oncogene EBNALP regulates YY1 DNA binding and alters host 3D genome organization. EMBO Rep 26(3):810\u2013835. https:\/\/doi.org\/10.1038\/s44319-024-00357-6","journal-title":"EMBO Rep"},{"issue":"5","key":"335_CR85","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1073\/pnas.87.5.1725","volume":"87","author":"M Woisetschlaeger","year":"1990","unstructured":"Woisetschlaeger M, Yandava CN, Furmanski LA, Strominger JL, Speck SH (1990) Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc Natl Acad Sci 87(5):1725\u20131729. https:\/\/doi.org\/10.1073\/pnas.87.5.1725","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"335_CR86","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/s42003-021-02501-7","volume":"4","author":"Y Yang","year":"2021","unstructured":"Yang Y, Ye X, Dai R, Li Z, Zhang Y, Xue W, Zhu Y, Feng D, Qin L, Wang X, Lei B, Liao S, Hao B (2021) Phase separation of Epstein-Barr virus EBNA2 protein reorganizes chromatin topology for epigenetic regulation. Commun Biol 4(1):967. https:\/\/doi.org\/10.1038\/s42003-021-02501-7","journal-title":"Commun Biol"},{"issue":"11","key":"335_CR87","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1128\/JVI.75.11.5119-5128.2001","volume":"75","author":"A Yokoyama","year":"2001","unstructured":"Yokoyama A, Tanaka M, Matsuda G, Kato K, Kanamori M, Kawasaki H, Hirano H, Kitabayashi I, Ohki M, Hirai K, Kawaguchi Y (2001) Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP): ability of EBNA-LP to induce latent membrane protein 1 cooperatively with EBNA-2 is regulated by phosphorylation. J Virol 75(11):5119\u20135128. https:\/\/doi.org\/10.1128\/JVI.75.11.5119-5128.2001","journal-title":"J Virol"},{"issue":"12","key":"335_CR88","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202153007","volume":"22","author":"X Zhang","year":"2021","unstructured":"Zhang X, Schuhmachers P, Mour\u00e3o A, Giansanti P, Murer A, Thumann S, Kuklik-Roos C, Beer S, Hauck SM, Hammerschmidt W, K\u00fcppers R, Kuster B, Raab M, Strebhardt K, Sattler M, M\u00fcnz C, Kempkes B (2021) PLK1-dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV-infected mice. EMBO Rep 22(12):e53007. https:\/\/doi.org\/10.15252\/embr.202153007","journal-title":"EMBO Rep"},{"key":"335_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1331730","volume":"14","author":"J Zhang","year":"2023","unstructured":"Zhang J, Sommermann T, Li X, Gieselmann L, De La Rosa K, Stecklum M, Klein F, Kocks C, Rajewsky K (2023) LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells. Front Immunol 14:1331730. https:\/\/doi.org\/10.3389\/fimmu.2023.1331730","journal-title":"Front Immunol"},{"issue":"36","key":"335_CR90","doi-asserted-by":"publisher","first-page":"14902","DOI":"10.1073\/pnas.1108892108","volume":"108","author":"B Zhao","year":"2011","unstructured":"Zhao B, Zou J, Wang H, Johannsen E, Peng C, Quackenbush J, Mar JC, Morton CC, Freedman ML, Blacklow SC, Aster JC, Bernstein BE, Kieff E (2011) Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proc Natl Acad Sci 108(36):14902\u201314907. https:\/\/doi.org\/10.1073\/pnas.1108892108","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"335_CR91","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.chom.2014.12.013","volume":"17","author":"H Zhou","year":"2015","unstructured":"Zhou H, Schmidt SCS, Jiang S, Willox B, Bernhardt K, Liang J, Johannsen EC, Kharchenko P, Gewurz BE, Kieff E, Zhao B (2015) Epstein-Barr virus oncoprotein super-enhancers control B cell growth. Cell Host Microbe 17(2):205\u2013216. https:\/\/doi.org\/10.1016\/j.chom.2014.12.013","journal-title":"Cell Host Microbe"}],"container-title":["Current Topics in Microbiology and Immunology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2025_335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T08:51:04Z","timestamp":1764665464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2025_335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":91,"URL":"https:\/\/doi.org\/10.1007\/82_2025_335","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"3 December 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was funded by NIH R01-CA140337","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"M.A.L. is a consultant for Moderna, Inc, Evrys Bio, and Merck and Co. J.M.C. and J.C.G. declare they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This chapter is a review of previously published accounts, as such, no animal or human studies were performed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}